U.S., Dec. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07281768) titled 'Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer' on Dec. 04.
Brief Summary: The purpose of this study is to evaluate the safety and clinical activity of combining cemiplimab, cemiplimab/fianlimab, or cemiplimab/REGN7075 with capecitabine/oxaliplatin (CAPOX) for the neoadjuvant treatment of patients with microsatellite stable (MSS) locally advanced rectal cancer (T2 node-positive, T3 node-negative, T3 node-positive).
Study Start Date: March, 2026
Study Type: INTERVENTIONAL
Condition:
Colorectal Cancer
Intervention:
DRUG: Oxaliplatin
Patients will rece...